Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

1.4K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

679
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Diabetic Nephropathy01:28

Diabetic Nephropathy

32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

682
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
682
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

559
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of centrally acting sympatholytic agents on the blood pressure response to renal denervation.

Journal of hypertension·2025
Same author

2025 Update on resistant hypertension in CKD: where do we stand and where do we go?

Clinical kidney journal·2025
Same author

Short- and mid-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure.

European journal of heart failure·2025
Same author

Effect of renal denervation on the lipid profile in patients with or without coronary artery disease.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Effects of Combination Treatment on Renal Endothelial Function in Type 2 Diabetes Mellitus.

Kidney international reports·2025

Related Experiment Video

Updated: May 1, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K

Renal denervation--implications for chronic kidney disease.

Roland Veelken1, Roland E Schmieder1

  • 1Department of Nephrology and Hypertension, University Hospital, University Erlangen/Nürnberg, Ulmenweg 18, 91054 Erlangen, Germany.

Nature Reviews. Nephrology
|April 16, 2014
PubMed
Summary

Catheter-based renal denervation shows promise for treating resistant hypertension and chronic kidney disease (CKD). This procedure may lower blood pressure and offer renoprotective benefits, but further trials are needed.

More Related Videos

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.2K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.6K

Related Experiment Videos

Last Updated: May 1, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.2K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.6K

Area of Science:

  • Nephrology
  • Cardiology
  • Interventional Cardiology

Background:

  • Resistant hypertension and chronic kidney disease (CKD) represent a significant clinical challenge.
  • Catheter-based renal denervation has emerged as a potential therapeutic strategy.
  • The precise role of renal denervation in patients with CKD requires further elucidation.

Purpose of the Study:

  • To evaluate the efficacy and safety of catheter-based renal denervation in patients with resistant hypertension and CKD.
  • To explore the potential renoprotective mechanisms of renal denervation beyond blood pressure reduction.

Main Methods:

  • Review of observational studies and randomized controlled trials on renal denervation.
  • Analysis of data regarding renal function, blood pressure control, and potential metabolic/inflammatory effects.

Main Results:

  • Most studies suggest renal denervation does not impair renal function and effectively reduces blood pressure in primary hypertension.
  • Potential benefits in CKD patients include reduced sympathetic tone, improved glucose metabolism, and reduced inflammation.
  • Data heterogeneity exists, with not all studies showing consistent positive outcomes.

Conclusions:

  • Renal denervation may offer significant benefits for patients with resistant hypertension and CKD.
  • Further large-scale randomized controlled trials are essential to confirm its clinical value and optimize its application in this population.